NON-ACETAMINOPHINE INDUCED LIVER FAILURE

Clinical trials for NON-ACETAMINOPHINE INDUCED LIVER FAILURE explained in plain language.

Never miss a new study

Get alerted when new NON-ACETAMINOPHINE INDUCED LIVER FAILURE trials appear

Sign up with your email to follow new studies for NON-ACETAMINOPHINE INDUCED LIVER FAILURE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Can a common antioxidant rescue failing livers?

Disease control Recruiting now

This trial tests whether adding N-acetylcysteine (NAC) to standard care improves survival in adults with acute liver failure not caused by acetaminophen. Sixty-two patients will be randomly assigned to receive NAC or standard care alone. The study tracks survival at 28 days, hosp…

Matched conditions: NON-ACETAMINOPHINE INDUCED LIVER FAILURE

Phase: NA • Sponsor: King Edward Medical University • Aim: Disease control

Last updated Aug 16, 2026 00:00 UTC

NON-ACETAMINOPHINE INDUCED LIVER FAILURE

Get alerted when new NON-ACETAMINOPHINE INDUCED LIVER FAILURE trials appear

Can a common antioxidant rescue failing livers?